URL details: kartosthera.com/advocacy
URL title:
Advocacy | Kartos Therapeutics
URL description:
Kartos Therapeutics is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232), KRT-232
URL last crawled:
2022-07-26
URL speed:
0.132 MB/s,
downloaded in 0.100 seconds
We found no external links pointing to this url.